Marcelo Bigal insider trades
Open-market stock purchases and sales by Marcelo Bigal, Director at Pacira BioSciences, Inc, from SEC Form 4 filings since Oct 6, 2023.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +84%.
Companies traded
- PCRX Pacira BioSciences, Inc: 3 buys, 1 sale, last Jun 10, 2026